Wellmedr vs Regenics: Pricing, Clinician Type, Compounding Differences
Wellmedr vs Regenics: quick verdict. If you prioritize lower advertised starting prices and lifetime locked-in offers, Wellmedr presents plans starting at $89/month and highlights lifetime locked-in pricing. If you prefer nurse-practitioner-led telehealth with a clear first-month promotional price and a LegitScript certified pharmacy network, Regenics documents a semaglutide first month at $139 and renewals at $199. All treatment requires clinician review and compounded medications are not FDA-approved.
Head-to-head: What the two providers actually offer
This comparison uses only supplied facts. Both Wellmedr and Regenics offer compounded GLP-1 medications including semaglutide and tirzepatide, require a licensed clinician to determine medical appropriateness, and note that compounded medications are not FDA-approved finished products. Differences appear in advertised starting pricing, clinician model, pharmacy network statements, and promotional terms.
1. Starting price and pricing structure
Wellmedr lists GLP-1 plans starting at $89/month and advertises semaglutide monthly plans starting at $49 a month in some landing content, with promotional Labor Day language about locking in savings. Wellmedr emphasizes lifetime locked-in pricing and no dose-based price increases. Regenics lists semaglutide at $139 for the first month with renewals at $199/month and tirzepatide at $189 first month with renewals at $279/month. Regenics notes promotional pricing applies to the first month only.
2. Clinician oversight and care model
Wellmedr states treatment plans require medical evaluation and clinician approval; landing content promises same-day review subject to clinician review. Regenics specifies licensed nurse practitioners review intake before anything is prescribed and that care is nurse-practitioner-led. Both require a licensed clinician to determine if treatment is clinically appropriate.
3. Pharmacy, compounding, and regulatory notes
Both providers offer compounded medications prepared by U.S. licensed compounding pharmacies. Wellmedr explicitly notes compounded medications are regulated by state Boards of Pharmacy but are not evaluated by the FDA for safety or efficacy and repeats that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Regenics likewise states compounded medications are not FDA-approved and notes its pharmacy network is LegitScript certified.
4. Shipping, promotions, and additional offerings
Wellmedr advertises same-day review plus free overnight shipping and various promotional claims including a Labor Day Sale and New Customer Offer language captured on landing content. It also uses assertive claims about on-time refills and money back guarantees in its captured content. Regenics advertises free shipping with medication compounded in the USA and offers Sermorelin peptide therapy as an add-on; Regenics also notes no insurance is required and that plans are FSA/HSA eligible.
| Criteria | Wellmedr | Regenics |
|---|---|---|
| Starting price | Semaglutide from $89/mo; Semaglutide listed as starting at $49/mo in landing content; Tirzepatide starting at $89/mo | Semaglutide $139 first month (renews $199/mo); Tirzepatide $189 first month (renews $279/mo) |
| Pricing model highlights | Lifetime locked-in pricing; no dose-based price increases; promotional sale language | Promotional first-month pricing; renewals increase unless otherwise stated |
| Clinician type | Treatment requires medical evaluation and clinician approval; same-day review claimed | Licensed nurse practitioners review intake and oversee prescriptions |
| Pharmacy and regulatory note | Compounded meds from licensed U.S. pharmacies; not FDA-evaluated for safety or efficacy | Compounded meds from U.S. pharmacies; pharmacy network LegitScript certified; not FDA-approved finished products |
| Shipping and extras | Free overnight shipping claimed; on-time refills guaranteed; money back language captured | Free shipping; Sermorelin peptide therapy offered; FSA/HSA eligible |
How differences affect a prospective patient
If lower advertised ongoing monthly cost and lifetime locked pricing are primary concerns, Wellmedr emphasizes starting plans from $89/month and lifetime locked-in pricing with no dose-based increases in captured content. If a clear nurse-practitioner model, first-month promotional pricing, and a stated LegitScript certified pharmacy network matter more, Regenics documents those specifics and also highlights a Sermorelin add-on.
Safety and claims to note
Both providers repeat that compounded medications are not FDA-approved finished products and are not reviewed by FDA for safety, effectiveness or quality. Wellmedr includes a safety notice about potential risks including thyroid C-cell tumors and medullary thyroid carcinoma and advises seeking immediate care for symptoms such as neck swelling or trouble swallowing. Regenics also states that treatment is available only when a licensed clinician determines it is medically appropriate.
Conclusion: Wellmedr vs Regenics
Wellmedr vs Regenics differs most on advertised starting price and pricing model, clinician presentation, pharmacy certification statements, and promotional terms. Both require clinician review and use compounded medications that are not FDA-approved finished products. Choose based only on the factual differences captured here.
Choose Wellmedr if you want lower advertised starting prices in the captured content, lifetime locked-in pricing, and claims of same-day review and free overnight shipping as shown in landing content.
Choose Regenics if you prefer nurse-practitioner-led telehealth with a documented first-month promotional price, a LegitScript certified pharmacy network, and an offered Sermorelin peptide add-on.